• LAST PRICE
    38.8700
  • TODAY'S CHANGE (%)
    Trending Down-0.4800 (-1.2198%)
  • Bid / Lots
    35.4300/ 1
  • Ask / Lots
    40.0000/ 1
  • Open / Previous Close
    39.4600 / 39.3500
  • Day Range
    Low 38.6000
    High 39.6450
  • 52 Week Range
    Low 23.1400
    High 45.2300
  • Volume
    929,634
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 39.35
TimeVolumeMIRM
09:32 ET6623939.425
09:34 ET23639.3744
09:36 ET10039.38
09:38 ET111039.5
09:39 ET17339.625
09:41 ET10039.43
09:43 ET10039.645
09:45 ET20039.49
09:50 ET80039.28
09:52 ET120039.22
09:54 ET30039.41
09:57 ET10039.4
09:59 ET84739.39
10:01 ET51239.36
10:06 ET10039.33
10:14 ET20039.09
10:15 ET40039.04
10:17 ET10039.04
10:19 ET130039.07
10:26 ET33939.1
10:28 ET30039.1
10:30 ET244038.86
10:32 ET60039.095
10:39 ET10039.125
10:44 ET71939.17
10:46 ET10039.135
10:48 ET40039.085
10:50 ET20039.055
10:51 ET20039.06
10:57 ET70038.915
11:00 ET20038.89
11:04 ET50038.73
11:06 ET30038.79
11:08 ET10038.89
11:11 ET2520038.825
11:13 ET583838.855
11:18 ET140038.88
11:22 ET10038.96
11:24 ET200038.95
11:29 ET10038.945
11:31 ET40038.785
11:33 ET160038.8
11:36 ET10038.79
11:42 ET10039.005
11:45 ET20039.005
11:49 ET10039.03
11:51 ET100038.93
11:58 ET30039.06
12:00 ET40038.98
12:02 ET90038.91
12:05 ET150039.065
12:09 ET50039.05
12:12 ET10039.035
12:14 ET30038.95
12:20 ET30039.005
12:21 ET10039.005
12:23 ET110038.92
12:27 ET20038.97
12:30 ET20038.945
12:32 ET444138.98
12:34 ET50038.99
12:36 ET50038.985
12:38 ET50038.94
12:39 ET50038.9
12:48 ET110038.85
12:50 ET20038.88
12:52 ET40038.96
12:54 ET10038.95
12:56 ET35638.9
12:57 ET70038.83
12:59 ET55138.82
01:03 ET10038.84
01:06 ET10038.87
01:08 ET10038.88
01:10 ET20039.01
01:14 ET20038.94
01:21 ET10039
01:24 ET10039.01
01:26 ET10038.92
01:28 ET140038.85
01:32 ET40038.91
01:33 ET10038.91
01:37 ET30039.015
01:39 ET90038.93
01:44 ET10039.02
01:46 ET100038.89
01:50 ET40038.82
01:51 ET14838.764
01:53 ET20038.87
01:57 ET10038.87
02:00 ET265038.74
02:02 ET40038.81
02:06 ET20038.88
02:08 ET10038.835
02:09 ET157638.86
02:13 ET39638.86
02:18 ET10038.87
02:22 ET10038.895
02:24 ET50038.95
02:27 ET28239
02:29 ET20038.91
02:31 ET20038.94
02:36 ET10038.95
02:38 ET10038.93
02:42 ET180038.96
02:44 ET120039.09
02:45 ET10039.11
02:47 ET22739.22
02:49 ET20039.225
02:51 ET152839.06
02:54 ET20039.16
02:56 ET80039.195
02:58 ET70339.14
03:00 ET94439.12
03:02 ET50039.15
03:03 ET120039.18
03:05 ET60039.07
03:07 ET105039.055
03:09 ET30039.05
03:12 ET80239.05
03:14 ET40039.08
03:16 ET180039.045
03:18 ET78639.07
03:20 ET20039.075
03:21 ET132738.985
03:23 ET20039.015
03:25 ET30038.93
03:27 ET96938.89
03:30 ET20038.88
03:32 ET80538.79
03:34 ET20038.76
03:36 ET10038.81
03:38 ET70038.68
03:39 ET65238.66
03:43 ET10038.68
03:45 ET195038.73
03:48 ET40038.69
03:50 ET41238.67
03:52 ET241538.62
03:54 ET159338.76
03:56 ET637338.7
03:57 ET745438.9
03:59 ET54166238.87
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMIRM
Mirum Pharmaceuticals Inc
1.9B
-16.2x
---
United StatesMNKD
MannKind Corp
1.8B
184.3x
---
United StatesXNCR
Xencor Inc
1.5B
-7.3x
---
United StatesVCEL
Vericel Corp
2.4B
2,462.7x
---
United StatesKNSA
Kiniksa Pharmaceuticals Ltd
1.9B
-143.4x
---
United StatesDVAX
Dynavax Technologies Corp
1.5B
112.3x
---
As of 2024-09-20

Company Information

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development and commercialization of therapies for debilitating rare and orphan diseases. It has three medicines: LIVMARLI (maralixibat) oral solution (Livmarli), Cholbam (cholic acid) capsules, and Chenodal (chenodiol) tablets. Livmarli is an orally administered, minimally-absorbed ileal bile acid transporter (IBAT) inhibitor (IBATi) that is used for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the United States and various other countries and for cholestatic pruritus in patient with progressive familial intrahepatic cholestasis (PFIC) in the United States. Cholbam is used for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders. It is also advancing its product candidate, volixibat, for the treatment of adult patients with cholestatic liver diseases.

Contact Information

Headquarters
989 EAST HILLSDALE BOULEVARD, SUITE 300FOSTER CITY, CA, United States 94404
Phone
650-667-4085
Fax
302-269-3855

Executives

Independent Non-Executive Chairman of the Board
Michael Grey
President, Chief Operating Officer
Peter Radovich
Chief Executive Officer, Co-Founder, Director
Christopher Peetz
Chief Financial Officer
Eric Bjerkholt
Chief Scientific Officer
Pamela Vig

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.9B
Revenue (TTM)
$264.4M
Shares Outstanding
47.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.15
EPS
$-2.40
Book Value
$5.32
P/E Ratio
-16.2x
Price/Sales (TTM)
7.1
Price/Cash Flow (TTM)
---
Operating Margin
-41.01%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.